Gene · 7072
Papers4,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Case of ALK-Positive Anaplastic Large Cell Lymphoma of the Male Breast. | Int Med Case Rep J | 2023 | 38020577 | PubTator, text mining | PubMed |
| Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients. | Neuromuscul Disord | 2023 | 38016875 | PubTator, text mining | PubMed |
| Time-resolved proteomic profiling reveals compositional and functional transitions across the stress granule life cycle. | Nat Commun | 2023 | 38012130 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas. | Cells | 2023 | 37998391 | PubTator, text mining | PubMed |
| Splicing under stress: A matter of time and place. | J Cell Biol | 2023 | 37988026 | PubTator, text mining | PubMed |
| [Immune Checkpoint Inhibitors Related Cystoureteritis: A Case Report and Literature Review]. | Zhongguo Fei Ai Za Zhi | 2023 | 37985157 | PubTator, text mining | PubMed |
| Crosstalk between alternative splicing and inflammatory bowel disease: Basic mechanisms, biotechnological progresses and future perspectives. | Clin Transl Med | 2023 | 37983927 | PubTator, text mining | PubMed |
| Copy-back viral genomes induce a cellular stress response that interferes with viral protein expression without affecting antiviral immunity. | PLoS Biol | 2023 | 37983241 | PubTator, text mining | PubMed |
| Mitochondria-associated membrane collapse impairs TBK1-mediated proteostatic stress response in ALS. | Proc Natl Acad Sci U S A | 2023 | 37967220 | PubTator, text mining | PubMed |
| Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2023 | 37958391 | PubTator, text mining | PubMed |
| Diagnostic Approach to Pulmonary B-Cell Lymphomas in Small Biopsies, with Practical Recommendations to Avoid Misinterpretation. | Diagnostics (Basel) | 2023 | 37958219 | PubTator, text mining | PubMed |
| Case Report: Radiation necrosis mimicking tumor progression in a patient with extranodal natural killer/T-cell lymphoma. | Front Radiol | 2023 | 37954919 | PubTator, text mining | PubMed |
| PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells. | PeerJ | 2023 | 37953789 | PubTator, text mining | PubMed |
| Primary cutaneous ALK-negative anaplastic large cell lymphoma: A case report. | Int J Surg Case Rep | 2023 | 37950994 | PubTator, text mining | PubMed |
| When Lymphoma Strikes the Pancreas: A Rare Presentation of Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma in a Human Immunodeficiency Virus-Positive Patient. | J Hematol | 2023 | 37936974 | PubTator, text mining | PubMed |
| Case Series of Hepatosplenic T-Cell Lymphoma: A Rare and Aggressive Disease. | Case Rep Oncol | 2023 | 37933311 | PubTator, text mining | PubMed |
| Case Report: Treatment of the rare B-cell lymphoblastic lymphoma with scalp lesion using rotation flap. | Front Oncol | 2023 | 37927459 | PubTator, text mining | PubMed |
| Prognostic significance of the systemic immune-inflammation index in patients with extranodal natural killer/T-cell lymphoma. | Front Oncol | 2023 | 37909016 | PubTator, text mining | PubMed |
| Intraoral Extranodal Natural Killer Cell/T-Cell Lymphoma of the Hard Palate. | Case Rep Dent | 2023 | 37908197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7072/papers?page=12